Source - LSE Regulatory
RNS Number : 7387U
Burford Capital Limited
07 April 2021
 

 

 

7 April 2021

 

 

COMPLETED PURCHASE OF SHARES BY EMPLOYEE BENEFIT TRUST

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, today announces that it was notified by the Trustee of the Burford Capital Employee Benefit Trust ("EBT") that it has completed the purchase in the market of 116,729 of Burford's Ordinary Shares in accordance with the Company's irrevocable instruction. Details of the completed purchases are as follows:

 

Date

Stock Exchange

Number of Ordinary Shares Acquired

Average Net Price Paid per Share

March 30

LSE

11,098

615.447p

March 30

NYSE

600

$8.43000

March 31

LSE

4,902

621.366p

March 31

NYSE

2,000

$8.82571

April 1

NYSE

40,733

$9.79294

April 5

NYSE

32,500

$10.1186

April 6

NYSE

24,896

$10.1971

 

The weighted average price of the purchases at the London Stock Exchange was 617.260p per share, while the weighted average price of the purchases at the New York Stock Exchange was $9.97058 per share.

 

As previously announced, the purchased shares will be held by the Trustee in the Company's EBT and used to satisfy vested awards made under Burford's Long Term Incentive Plan. The EBT is a discretionary trust for the benefit of the employees of the Company and its subsidiaries.

 

 

For further information, please contact:

 

Burford Capital Limited


Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176



Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Kevin Cruickshank (NOMAD)


Charlie Farquhar / Jonathan Abbott (Joint Broker)




Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson


Tony White




 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information, please visit www.burfordcapital.com.

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934 regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with the US Securities and Exchange Commission, other information sent to our security holders, and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on  numerous assumptions and that our actual results of operations, including our financial condition and liquidity and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this report. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 24, 2021. In addition, even if our results of operations, including our financial condition and liquidity and the development of the industry in which we operate, are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this report, whether as a result of new information, future events, a change in our views or expectations or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREAKLXEFSFEFA
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.